1. Home
  2. TMCI vs MCRB Comparison

TMCI vs MCRB Comparison

Compare TMCI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$1.38

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.35

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
MCRB
Founded
2014
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
139.7M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
TMCI
MCRB
Price
$1.38
$9.35
Analyst Decision
Hold
Hold
Analyst Count
6
3
Target Price
$4.77
$14.33
AVG Volume (30 Days)
852.4K
48.4K
Earning Date
05-19-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.64
Revenue
$212,690,000.00
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.65
N/A
P/E Ratio
N/A
$14.72
Revenue Growth
1.59
N/A
52 Week Low
$1.31
$0.36
52 Week High
$8.84
$29.98

Technical Indicators

Market Signals
Indicator
TMCI
MCRB
Relative Strength Index (RSI) 34.96 40.94
Support Level $1.31 $6.99
Resistance Level $3.06 $9.60
Average True Range (ATR) 0.15 0.51
MACD 0.01 0.24
Stochastic Oscillator 9.55 43.33

Price Performance

Historical Comparison
TMCI
MCRB

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: